Cargando…
COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study
Patients with COVID-19 ARDS have distinct physiological and immunological phenotypes compared to patients with non-COVID ARDS. Patients with COVID-19 ARDS (n = 32) had a significant improvement in PaO(2): FiO(2) ratio (p = 0.046) following low-dose steroid treatment, unlike patients with non-COVID A...
Autores principales: | Longobardo, Alessia, Snow, Timothy Arthur Chandos, Montanari, Cecilia, Shulman, Robert, Singer, Mervyn, Arulkumaran, Nishkantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680030/ https://www.ncbi.nlm.nih.gov/pubmed/33260010 http://dx.doi.org/10.1016/j.jcrc.2020.11.012 |
Ejemplares similares
-
Steroids in ARDS: more light is being shed
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022) -
Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
por: Longobardo, Alessia, et al.
Publicado: (2021) -
“L'histoire se répète”, one size does not fit all. Author’s reply
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2021) -
Clarithromycin as an immunomodulator in sepsis: still a (IN)CLASS act
por: Snow, Timothy Arthur Chandos, et al.
Publicado: (2022)